Management of patients with cardiopulmonary comorbidities awaiting liver transplantation

Abstract

Purpose of review: The need for liver transplant continues to rise especially among those with metabolic dysfunction associated steatotic liver disease. Consequently, more transplant candidates have concurrent cardiopulmonary comorbidities. This review summarizes contemporary developments in cardiopulmonary care in liver transplant candidates.

Recent findings: Recent guidelines recommend noninvasive anatomic cardiovascular assessment before invasive coronary angiography for evaluation of coronary artery disease. Post-PCI DAPT can be used for as short as 1 month before waitlist activation. Practice-based guidance recommends echocardiographic surveillance on the waitlist especially with the evolving data on the impact of Cirrhotic Cardiomyopathy. Emerging evidence suggests that guideline directed medical therapy for heart disease is safe in patients with advanced liver disease. Updated portopulmonary hypertension guidelines emphasize revised screening and diagnostic thresholds, early initiation of medical therapy, and timely liver transplant evaluation.

Summary: Management of cardiopulmonary comorbidities in liver transplant candidates continues to advance yet remains nuanced requiring a multidisciplinary approach for optimal care.

Speckle Tracking Analysis of the Left and Right Heart in Type 1 Diabetes Patients with End-Stage Renal Disease Awaiting Simultaneous Pancreas-Kidney Transplantation.
Kun Zhang, Katharina Haag, Ingo Hilgendorf +3
Diagnostics (Basel, Switzerland)29 Sep 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC
A randomized controlled trial of a multidisciplinary collaborative fatigue management program for patients undergoing hematopoietic stem cell transplantation: study protocol
Jianli Zhang, Liya Ren, Liwei Xu +5
Trials10 Oct 2026Peer-reviewedCC BY-NC-ND 4.0OncologyCrossref
Maximizing cardiopulmonary support as a minimally invasive platform—using peripheral parallel veno-venous and veno-arterial extracorporeal membrane oxygenation and axillary impella 5.5 as a bridge to heart–lung transplantation
Enock Adjei, Amir Teimouri Dereshgi, Kevin C. McGann +11
JHLT open14 Sep 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
Association Between a Nurse-Led Mobile Health Intervention and Medication Adherence and Self-Management in Patients After Hair Transplantation: A Retrospective Cohort Study
Lu Xu, Haihua Chen, Yali Wu +2
Clinical, Cosmetic and Investigational Dermatology30 Oct 2026Peer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
STABILOOP, a cohort trial to assess automated insulin delivery in the management of patients living with type 1 diabetes who are eligible for islet transplantation.
Quentin Perrier, Matthieu Roustit, Orianne Villard +11
Trials1 Aug 2026Peer-reviewedCC BY-NC-NDFull text1 citedEndocrinology & metabolismEurope PMCPMCDOAJ

Cite

BibTeX RIS

BibTeX

@article{liu2026management,
  title = {{Management of patients with cardiopulmonary comorbidities awaiting liver transplantation}},
  author = {Alex Liu and Manhal Izzy},
  journal = {Current Opinion in Organ Transplantation},
  year = {2026},
  month = sep,
  doi = {10.1097/mot.0000000000001312},
  url = {https://doi.org/10.1097/mot.0000000000001312},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Management of patients with cardiopulmonary comorbidities awaiting liver transplantation
AU  - Alex Liu
AU  - Manhal Izzy
PY  - 2026
DA  - 2026/09/25
JO  - Current Opinion in Organ Transplantation
DO  - 10.1097/mot.0000000000001312
UR  - https://doi.org/10.1097/mot.0000000000001312
AB  - Purpose of review: The need for liver transplant continues to rise especially among those with metabolic dysfunction associated steatotic liver disease. Consequently, more transplant candidates have concurrent cardiopulmonary comorbidities. This review summarizes contemporary developments in cardiopulmonary care in liver transplant candidates.  Recent findings: Recent guidelines recommend noninvasive anatomic cardiovascular assessment before invasive coronary angiography for evaluation of coronary artery disease. Post-PCI DAPT can be used for as short as 1 month before waitlist activation. Practice-based guidance recommends echocardiographic surveillance on the waitlist especially with the evolving data on the impact of Cirrhotic Cardiomyopathy. Emerging evidence suggests that guideline directed medical therapy for heart disease is safe in patients with advanced liver disease. Updated portopulmonary hypertension guidelines emphasize revised screening and diagnostic thresholds, early initiation of medical therapy, and timely liver transplant evaluation.  Summary: Management of cardiopulmonary comorbidities in liver transplant candidates continues to advance yet remains nuanced requiring a multidisciplinary approach for optimal care.
SN  - 1087-2418
SN  - 1531-7013
ER  -

Abstract

Related

Cite